Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pott

Showing results (1051-1060 of 1,295) with videos related to

Pageof 130
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)Anne T Nies, Elke Schaeffeler, Heiko van der Kuip, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Bile acid fitness determinants of a <i>Bacteroides fragilis</i> isolate from a human pouchitis patientAretha Fiebig, Matthew K Schnizlein, Selymar Pena-Rivera, et al.
Leukemia|December 18, 2013
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersM Ladetto, M Brüggemann, L Monitillo, et al.
Clinical Neuropathology|May 16, 2022
An aggressive lactotroph pituitary tumor in a young male: A pituitary carcinoma without metastasisFriederike E Roelandt-Schumann, Rob A Vergeer, Astrid G W Korsten-Meijer, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
Leukemia|February 13, 2004
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemiaM Brüggemann, V H J van der Velden, T Raff, et al.
Haematologica|June 12, 2025
Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma AllianceChristian Schmidt, Gabriel Scheubeck, Vindi Jurinovic, et al.
Heart Rhythm|November 15, 2011
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failurePeter Milberg, Christian Pott, Gerrit Frommeyer, et al.
Basic Research in Cardiology|February 14, 2012
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanismsChristian Pott, Adam Muszynski, Matthias Ruhe, et al.
Elife|February 25, 2016
The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammationAgnieszka M Kabat, Oliver J Harrison, Thomas Riffelmacher, et al.
Pageof 130

Showing results (1051-1060 of 1,295) with videos related to

Sort By:
Pageof 130
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)Anne T Nies, Elke Schaeffeler, Heiko van der Kuip, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Bile acid fitness determinants of a <i>Bacteroides fragilis</i> isolate from a human pouchitis patientAretha Fiebig, Matthew K Schnizlein, Selymar Pena-Rivera, et al.
Leukemia|December 18, 2013
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersM Ladetto, M Brüggemann, L Monitillo, et al.
Clinical Neuropathology|May 16, 2022
An aggressive lactotroph pituitary tumor in a young male: A pituitary carcinoma without metastasisFriederike E Roelandt-Schumann, Rob A Vergeer, Astrid G W Korsten-Meijer, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
Leukemia|February 13, 2004
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemiaM Brüggemann, V H J van der Velden, T Raff, et al.
Haematologica|June 12, 2025
Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma AllianceChristian Schmidt, Gabriel Scheubeck, Vindi Jurinovic, et al.
Heart Rhythm|November 15, 2011
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failurePeter Milberg, Christian Pott, Gerrit Frommeyer, et al.
Basic Research in Cardiology|February 14, 2012
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanismsChristian Pott, Adam Muszynski, Matthias Ruhe, et al.
Elife|February 25, 2016
The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammationAgnieszka M Kabat, Oliver J Harrison, Thomas Riffelmacher, et al.
Pageof 130